Xanax to Valium: A Safe Tapering Solution for Benzodiazepine Withdrawal

Why is Xanax so hard to taper directly?

Xanax, or alprazolam, is a short-acting benzodiazepine, and that is the whole difficulty. Table 1 in the first chapter of the Ashton Manual lists its half-life at 6 to 12 hours, and the drug’s own United States Food and Drug Administration (FDA) label puts the average at about 11 hours in healthy adults. A dose taken in the morning has largely worn off by evening.

Most people asking how to get off Xanax took it exactly as prescribed, often for years, and now find that they cannot stop without symptoms. Physical dependence is not addiction. The gamma-aminobutyric acid (GABA) receptors adapted to the drug’s steady presence, and the treatment for that is a medical taper, not a program built for a different problem.

That short half-life is the first obstacle to the taper. A person who takes Xanax three times a day rides a wave of rising and falling blood levels, and in the troughs between doses the nervous system can begin to withdraw, a pattern known as interdose withdrawal. The Xanax label itself reports early morning anxiety and anxiety emerging between doses in people with panic disorder taking prescribed maintenance doses.

The second obstacle is the tablet. Xanax comes in 0.25 mg, 0.5 mg, 1 mg and 2 mg strengths, and because 0.5 mg of alprazolam is roughly as strong as 10 mg of diazepam, even the smallest tablet is a large step. Near the end of a taper, the pieces a person needs are smaller than any pill cutter can make, and the alprazolam-specific steps are set out in the practice’s Xanax tapering guide.

Stopping abruptly is the one thing the label and the Manual agree on. In 2020 the FDA required the boxed warning on every benzodiazepine label to be updated to cover physical dependence and withdrawal, and the Xanax label now states that abrupt discontinuation or rapid dosage reduction after continued use may precipitate acute withdrawal reactions that can be life-threatening, including seizures. Call emergency services for a seizure or any other medical emergency during withdrawal.

What is a crossover taper?

A crossover taper is the Ashton Manual’s method of replacing a short-acting benzodiazepine with a long-acting one before the reductions begin. Professor C. Heather Ashton, whose Manual is published online at benzo.org.uk, chose diazepam, or Valium, and Chapter II explains why. It is one of the most slowly eliminated benzodiazepines, with a half-life that Chapter II puts at up to 200 hours once its active metabolite is counted, and that Table 1 lists at 20 to 100 hours for the drug itself, so its blood level falls gently after each reduction.

Diazepam also comes in a 2 mg tablet scored down the middle, which halves cleanly to 1 mg, and it can be prepared as a liquid, so the final steps can be made very small. The Manual’s Table 1 lists 0.5 mg of alprazolam as roughly equivalent to 10 mg of diazepam, with the note that equivalents are approximate and vary between individuals.

Think of Xanax as a light switch flicked on and off several times a day, and diazepam as a dimmer that can be turned down by degrees so small the eyes adjust without noticing. The switch is not there to lower the dose. It is there to make the lowering smooth, and the practice explains the reasoning at greater length in why the Ashton Manual recommends switching to diazepam before a benzo taper.

The substitution happens in stages, one dose at a time.

Does the switch happen all at once? No, and the Manual is explicit: the switch-over is carried out gradually, in stepwise fashion, one dose at a time, because a person moved straight from a full daily dose of Ativan (lorazepam) to the whole diazepam equivalent is liable to become extremely sleepy. Diazepam takes days to build up to a steady level, and the body needs that time.

So, in the Manual’s schedules one of the day’s Xanax doses, the evening dose first, is replaced by its diazepam equivalent, and the person stays there for a week or two before the next stage. When that feels settled, the next dose is replaced, and then the next. The Manual’s Schedules 1 and 7, written for people taking 6 mg and 4 mg of alprazolam a day, spread the substitution across many stages at intervals of one to two weeks.

The switch does not have to be complete, and some people keep a small alprazolam dose in place for a time while diazepam does the rest of the work. The figures above describe the Manual’s own examples, not a plan for any reader, and the steps for one person are worked out with that person’s own prescriber.

Yet, the pace is not the doctor’s alone to set. Professor Ashton’s instruction to the patient is plain: be in control of your own schedule, and do not let your doctor impose a deadline. In Dr. Leeds’ practice, a stage is repeated for as long as the patient needs it, and nobody moves on because a calendar says so.

Then the diazepam is tapered slowly, over months, at the patient’s pace.

Once the person is on diazepam alone and feels level, with no extra doses taken to get through a bad afternoon and no withdrawal between doses, the reductions begin. Chapter II of the Manual suggests reducing by up to one tenth of the dose at each step, every one to two weeks, with the steps getting smaller as the dose falls, and it estimates 30 to 60 weeks for its own example of a person starting from 40 mg of diazepam a day. It adds that many people have taken a year or more.

That shape is what the Maudsley Deprescribing Guidelines call hyperbolic dose reduction. The last few milligrams of a benzodiazepine carry a larger share of its effect than the first few, so they are taken away in smaller pieces, and compounded liquid diazepam allows pieces no tablet could provide. The diazepam stage of the taper is described further in tapering off Valium (diazepam).

What happens when a step is too big? The person holds, or goes back up one step, and then moves more slowly, which is what the Xanax label advises for alprazolam itself: pause the taper or return to the previous dose, then decrease more slowly. Severe symptoms are the signal to slow down, not to press on.

A hold is not a failure. It is the method working.

Who does the crossover taper suit, and who may do better without it?

The crossover suits the person the Manual wrote it for: someone taking Xanax several times a day, feeling withdrawal between doses, or on a dose high enough that the tablet steps are steep. For that person, diazepam turns a jagged taper into a smooth one, and the switch itself often eases the interdose symptoms.

Unfortunately, the long half-life cuts both ways. Diazepam builds up over days, and in an older adult, or a person whose liver clears drugs slowly, it can build up further than intended and cause daytime sedation, unsteadiness and slowed thinking. The Xanax label already advises lower starting doses for older patients and for people with liver impairment, and the caution applies with more force to a drug that lingers for a week.

Some people simply do better staying on alprazolam. A direct hyperbolic taper of Xanax, using a compounded liquid so the reductions can be tiny, avoids adjusting to a new drug, and some patients who have tried the switch report feeling worse on diazepam than the table predicts. The Manual itself says the equivalents are only approximate and differ between individuals, and Dr. Leeds treats that as a clinical fact, not a footnote.

So, the choice is made with each patient, not for them. Other prescriptions the person takes, including any other psychiatric medications Dr. Leeds also helps patients taper, affect how the plan is built, so he reviews the whole list first. Whether the answer is a crossover taper or a direct one, the pace belongs to the patient.

How does Dr. Leeds’ practice handle a Xanax to Valium crossover taper?

People searching for Xanax detox often picture a facility and a discharge date. What Dr. Leeds offers instead is a gradual, medically supervised taper over months, from the patient’s own home, by telemedicine throughout Florida. His Fort Lauderdale practice is a concierge practice with one physician, and there is no facility, no required meeting and no fixed timeline.

Care begins with an informed-consent conversation in the proper order: the risks of continuing Xanax and the risks of tapering it first, the alternatives, including a direct taper and not tapering yet, an exit plan, and the patient’s right to decline or pause at any point. From there the plan follows the Ashton Manual where it helps and the Maudsley principle of smaller steps at lower doses. The method is described further under medically supervised benzodiazepine tapering and the Ashton Manual approach.

Fortunately, there is no reason to fear a Xanax taper when the plan is gradual and the pace belongs to the patient. For people in Florida who have taken Xanax for years and want a physician who will not impose a deadline, Dr. Leeds’ practice offers a slow, patient-directed crossover taper by telemedicine statewide. Contact Dr. Leeds to ask about a Xanax to Valium crossover taper.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.